Newly approved cancer drugs in China - innovation and clinical benefit

Affiliations

• ¹ Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
• ² Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
• ³ Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China. guanxiaodong@pku.edu.cn.
• ⁴ International Research Centre for Medicinal Administration, Peking University, Beijing, China. guanxiaodong@pku.edu.cn.